89 related articles for article (PubMed ID: 25537915)
1. [Expressions of Bim and ERKs in multidrug-resistant hepatic carcinoma cells].
Yan F; Wang X; Ma Q; Yuan S; Jiang N
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1838-41. PubMed ID: 25537915
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells.
Yan F; Wang XM; Pan C; Ma QM
World J Gastroenterol; 2009 Mar; 15(12):1443-51. PubMed ID: 19322916
[TBL] [Abstract][Full Text] [Related]
3. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
Yan F; Wang XM; Pan C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531
[TBL] [Abstract][Full Text] [Related]
4. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
5. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
6. EGF reverses multi-drug resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.
Yan F; Bai LP; Gao H; Zhu CM; Lin L; Kang XP
Asian Pac J Cancer Prev; 2014; 15(6):2619-23. PubMed ID: 24761873
[TBL] [Abstract][Full Text] [Related]
7. Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression.
Yuan WQ; Zhang RR; Wang J; Ma Y; Li WX; Jiang RW; Cai SH
Oncotarget; 2016 May; 7(21):31466-83. PubMed ID: 27129170
[TBL] [Abstract][Full Text] [Related]
8. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
9. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU].
Tang HH; Zhou M; Liang G
Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of human multidrug-resistant hepatocellular carcinoma cell line (HepG2/Adm) and biological characteristics evaluation].
Zhai BJ; Wu F; Shao ZY; Hu K; Wang ZB
Ai Zheng; 2004 Apr; 23(4):391-5. PubMed ID: 15087025
[TBL] [Abstract][Full Text] [Related]
11. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
[TBL] [Abstract][Full Text] [Related]
12. [Study on sensitivity to chemotherapy by combination therapy with tumor necrosis factor-alpha and bromocriptine in the multidrug resistant subcell line of HepG2].
Ding L; Chen XP; Zhang ZW; Jing K; Cao B; Zhu P; Li J; Zhang DY
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1644-7. PubMed ID: 17359700
[TBL] [Abstract][Full Text] [Related]
13. Role and mechanisms of microRNA‑503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells.
Wang D; Zhang N; Ye Y; Qian J; Zhu Y; Wang C
Mol Med Rep; 2014 Dec; 10(6):3268-74. PubMed ID: 25269574
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
16. [Abnormal expression of circulating nuclear factor-κB in hepatocellular carcinoma and reversal of multidrug resistance through intervening its gene transcription].
Yao M; Gu X; Wang L; Cai Y; Wu W; Shi Y; Dong Z; Yao D
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(10):761-6. PubMed ID: 27055634
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
[TBL] [Abstract][Full Text] [Related]
18. [Reversal of stemness in multidrug-resistant hepatocellular carcinoma cells by SIS3].
Yan W; Wen T; Lin S; Liu Z; Yang W; Wu G
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):731-5. PubMed ID: 26813590
[TBL] [Abstract][Full Text] [Related]
19. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
[TBL] [Abstract][Full Text] [Related]
20. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]